Drug prices almost always fall after a manufacturer’s patent expires and generics hit the market. But with its blockbuster cholesterol-fighting drug Lipitor going off-patent this week, drug maker ...

Pfizer received a flurry of attention toward the end of November as its blockbuster statin Lipitor came to the end of its patent protection. Many media outlets were impressed with Pfizer’s aggressive, ...

TORONTO/NEW YORK (Reuters) - Apotex Inc said on Wednesday it would immediately launch in Canada a copycat form of Pfizer Inc's blockbuster Lipitor cholesterol fighter, and Pfizer vowed to fight back ...

LONDON, Feb 12 (Reuters) - India's Ranbaxy Laboratories Ltd. , which is fighting to overturn Pfizer Inc.'s exclusivity on cholesterol fighter Lipitor, has launched a generic form of the world's ...

Ranbaxy Pharmaceuticals is recalling several doses of its generic version of Lipitor because some batches of the cholesterol fighter may contain small glass particles. The generic drugmaker’s website ...

NEW YORK — A patent victory on its biggest-selling drug Lipitor boosted Pfizer Inc.'s shares nearly 8 percent Monday as a major uncertainty was eliminated, even though other significant challenges ...

Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors. FOR IMMEDIATE RELEASEnew york city, New York, United States of America (Free-Press-Release.com) July 26, 2011 ...

TRENTON, N.J. - Sales of cholesterol blockbuster Lipitor plunged by half barely a week after the world's top-selling drug got its first U.S. generic competition, new data show. That's despite an ...

TRENTON, N.J. -- Ranbaxy Pharmaceuticals Inc. has recalled dozens of lots of its generic version of cholesterol drug Lipitor, because some may contain tiny glass particles, the latest in a string of ...